To own Ducommun, you need to believe the push into higher value defense electronics, including missile content, can offset the drag from an unprofitable base and exposure to commercial aerospace cycles. The recent US$35 million PAC-3 award fits that story by reinforcing backlog and visibility, but it does not change the fact that Ducommun is still loss making today.
Right now, the near term swing factor is execution on facility consolidation, cost savings and mix shift toward engineered products, while managing transfers and recertifications without disruption. The biggest risk remains concentration in defense platforms and timing uncertainty around Boeing and Spirit AeroSystems build rates, which could still create choppy revenue and margin outcomes.
The PAC-3 electronics agreement from Simmonds Precision Products looks most relevant to the current Ducommun story. It ties directly into missile and munition exposure under VISION 2027 and leans into areas where the group has been highlighting strong order activity and higher value content within Electronic Systems.
For catalysts, this award contributes to the defense backlog that investors are watching alongside margin progress and automation benefits expected into 2025 and 2026. Execution risk does not go away though. Ducommun still has to integrate this extra PAC-3 workload smoothly into the Tulsa performance center while juggling facility consolidation and commercial aerospace volatility.
Ducommun's current narrative assumes revenue rising to US$1.1b and earnings reaching US$146.1 million by 2029. That path implies 8.4% yearly revenue growth and an earnings swing of about US$167.3 million from a loss of US$21.2 million today to the 2029 consensus figure.
Uncover why Ducommun's fair value indicates a 27% potential upside to its current price before that discount closes.
One optimistic twist in the alternate Ducommun story is missile driven operating leverage. The most bullish analysts were already penciling in about US$1.1b of revenue and US$142.6 million of earnings by 2029 before this PAC 3 update. You can treat this new award as a prompt to compare those upbeat expectations with more cautious views.
Explore 2 other Ducommun fair value estimates, including one that suggests up to 33% potential upside from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If the Ducommun story has you thinking about portfolio upgrades, it can help to cast the net wider and scan for other businesses that fit your risk, income, or value preferences using the Simply Wall St Screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com